| Name | Recombinant Human VSIG1 Fc Chimera Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 9708-VS |
| Category | Protein |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Mouse myeloma cell line, NS0-derived Human VSIG1 (Val22-Gly234) Accession # Q86XK7-1 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
| Purity | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
| Bioactivity | Measured by its ability to inhibit anti-CD3 antibody induced IL-17 secretion by human peripheral blood mononuclear cells (PBMC). The ED 50 for this effect is 5-25 μg/mL. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | Q86XK7-1 |
| Gene | VSIG1 |
| Sequence | Val22 |
| Supplier Page | Shop |